Vincerx Pharma, Inc. Proceeds from Issuance Initial Public Offering
Vincerx Pharma, Inc. reported Proceeds from Issuance Initial Public Offering of $15.71 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2025-03-27
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2024-12-31 was $961.00K.
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2024-09-30 was $0.00.
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2023-12-31 was $0.00.
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2023-09-30 was $0.00.
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for fiscal 2024 was $15.71M.
- Vincerx Pharma, Inc. proceeds from issuance initial public offering for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2024-12-31 | $961.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $961.00K derived: sum of 2 quarters · filed 2025-03-27 | $15.71M 10-K · filed 2025-03-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $14.75M 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $14.75M 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 10-K · filed 2025-03-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 |